ArticleFrontiers in pharmacology2022

Novel 1,2,3-Triazole Erlotinib Derivatives as Potent IDO1 Inhibitors: Design, Drug-Target Interactions Prediction, Synthesis, Biological Evaluation, Molecular Docking and ADME Properties Studies.

Gui-Qing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.